Pfizer Receives European Approval For Avastin® (Bevacizumab) Biosimilar

Published date20 February 2019
Law FirmGoodwin
Subject MatterEuropean Commission,Prescription Drugs,Biosimilars,Pfizer

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT